A typical biochemical defect in WAS appears to be related to reduced and/or abnormal expression of the membrane glycoprotein, CD43, on most blood cells.'-' ' CD43 (formerly referred to as sialophorin or leukosialin) is a putative regulator of cell maturation, survival, and/or activation" and is encoded by a gene located on chromosome 16 ql 1.2.12 The CD43 defect is secondary rather than primary in WAS, because the disease maps to the short arm of the X chromosome 0 1996 by The American Society of Hematology. 0006-4971/96/8711-0007$3.00/0 characterized by the presence of thrombocytopenia with a broad spectrum of platelet size, including giant platelets, and was inherited as an autosomal dominant trait. This last finding led us to hypothesize a mutation of the CD43 gene. However, Southern blot analysis failed to detect structural abnormalities of this gene, and genotype analysis ruled out the possibility that a CD43 allele might be shared by the affected individuals. These findings indicate that an alteration($) of an autosomal gene distinct from the CD43 gene is responsible for the disease. Thus, results from this family, providing the first observation of an autosomally transmitted WAS variant, indicate that genetic mechanism(s) leading to WAS are more complex than previously recognized.
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patients, apparently encodes a proline-rich protein that is likely to play a role in regulating the expression of CD43 either directly or through a more complex mechanism involving another gene product(s). A contribution to the understanding of the molecular mechanism(s) leading to WAS is provided by the family reported here. This family, studied over three generations, has several members showing variable expression of clinical and laboratory manifestations of WAS, including decreased CD43 expression on T lymphocytes. At variance with classic X-linked WAS, this disorder was characterized by a mild thrombocytopenia showing a broad spectrum of platelet size, including giant platelets, and by a segregation compatible with an autosomal dominant inheritance, thus suggesting the existence of an alternative genetic mechanism(s) for this disorder.
SUBJECTS AND METHODS
Case report and family history. The propositus, an 18-year-old boy (IV:2 in Fig l) , came to our observation for asymptomatic thrombocytopenia (60 to 80 X 109/L platelets). His medical history is mainly characterized by recurrent episodes of bacterial infections since early childhood. In particular, he has experienced bilateral recurrent otitis since the second month of life (four to five episodes per year), and from the sixth month of life, he has had recurrent episodes of sinusitis, tonsillitis, and cystitis of bacterial etiology. One episode of pneumonia occurred at the age of 10 months and one episode of hematuria at the age of 3 years. Measurements of Ig serum levels performed at ages 3, 6, and 17 years consistently showed low IgM titers (<30 mg/dL), normal IgG and IgA, and slightly increased IgE (130 UI/mL; normal, < 100). Serum isoagglutinin titer against B was decreased (1:8). Since the age of 6, the patient has developed severe allergic diathesis. At the time of our observation, he still had recurrent episodes of sinusitis, otitis, and allergic manifestations, and he has recently suffered from relapsing episodes of myositis.
A review of the family history showed that WAS-related symptoms were highly variable among family members on the patemal side (Fig 1) . The propositus' sister (IV:3), aged 17, has suffered from eczema and severe allergic asthma since childhood. From the age of 16, she has suffered from relapsing herpes zoster episodes resistant to acyclovir treatment, and a recrudescence of eczema was concomitant to these relapsing episodes. Polyarthritis episodes of the major joints were observed at the age of 17. Serum Ig concentrations were normal except for IgE levels, which were increased (254 UI/mL; normal, i 100). Serum isoagglutinins against B were slightly decreased (1:16) . Her father (111:3), aged 44, has had a history of eczema since early childhood and was found to have mild thrombocytopenia. Ig serum levels measured on several occasions were consistently normal, whereas serum isoagglutinin titer was decreased (1%). At the age of 20, he developed ulcerative colitis. His brother (III:4) was thrombocytopenic and had a history of recurrent infections. Since the age of 5, he has suffered from glomerulonephritis of unknown origin, for which he had been treated by hemodialysis since the age of 18; he underwent renal transplantation at the age of 34. The grandmother of the propositus (II:4) had thrombocytopenia and neutropenia, and her sister (II:5), aged 65, has suffered from eczema and nonimmune thrombocytopenia (60 X 109L platelets) since early childhood. In her fifth decade, she developed severe nonseptic chronic polyarthritis and chronic glomerulonephritis leading to renal failure. Individual III:5 had isolated mild thrombocytopenia. Family member II:3 died at the age of 87, and his reported history was negative for any immunologic disorder. The renal function of family members 11:4, 111:3, III:5, II1:6, IV:2, and IV:3 was tested on several occasions and found to be normal. No evidence of ocular and/or hearing abnormalities was detected in any member of this kindred. The distribution of WAS-related manifestations among the affected family members clearly indicates a mendelian autosomal dominant inheritance (Fig 1) .
Platelet counts were performed on EDTA-anticoagulated venous blood in an electronic particle counter (System 9OOO; Baker Diagnostic, Bethlehem, PA) and by contrast-phase microscopy. For measuring mean platelet volume (MPV), blood samples were collected in tubes containing a solution of sodium citrate (0.38% final concentration) and PGEl (1 p m o m final concentrat i~n ) . '~. '~ Normal values for MPV of citrated platelets are 6.8 2 0.16 fL (mean t SD), and giant platelets were defined as having a MPV more than 10 Platelet aggregation studies were performed on platelet-rich plasma obtained by centrifuging citrated (0.38% final concentration) venous blood for 15 minutes at 100g. Aggregation measurements were made in a Born aggregometer (ELVI-840 Elvi, Milan, Italy) using bovine tendon collagen, adenosine diphosphate (ADP), and ristocetin as aggregating agents. Adenosine triphosphate (ATP) release was evaluated in a luminescence aggregometer (Chronolog Corp, Harvestone, PA) using the luciferiduciferase reaction.
For ultrastructural studies, platelets and lymphocytes were prefixed in suspension with 2% paraformaldehyde in 0.1 m o m phosphate buffer, pH 7.4, for 5 minutes and then washed twice with phosphate-buffered saline (PBS) plus 3% sucrose. Platelet diameters were measured by electron microscope analysis, and on the basis of this method, giant platelets were defined Platelet studies.
EZectron microscopy analyses.
as having a diameter more than 5 pm.I6 For the immunogold labeling procedure, the cells were washed in PBS containing 0.1% bovine serum albumin (BSA) and treated with anti-CD43 murine monoclonal antibody (MoAb) (DAKOPATTS AB, Alvsjo, Sweden) for 30 minutes. The murine antibody was revealed using goat antimouse gold-conjugated antibody (BioCell Laboratories, Rancho-Domingues, CA) at a 1/50 ratio. After washing, cells were fixed in 2% glutaraldehyde in 0.1 m o m phosphate buffer, pH 7.4, and processed as described earlier. After labeling, cells were postfixed in 1% osmium tetroxide for 30 minutes, dehydrated in graded ethanol, and embedded in Epon 812. Thin sections were stained with uranyl acetate and lead citrate and examined in a Philips EM 400 transmission electron microscope (Philips Corp. Eindhoven, The Netherlands).
For lymphocyte surface antigens, small aliquots of whole blood were incubated under standard conditions with the following fluorescein isothiocyanate-or phycoerythrin-conjugated antibodies: CD3, CD4, CD8, CD16, CD56, CD19, and HLA-DR (Simultest; Becton Dickinson, Mountain View, CA). CD43 antigen expression was analyzed by incubating the cells with anti-CD43 MoAb (DAKOPATTS). Cells were labeled with fluorescein-conjugated goat antimouse Igs (Ortho Diagnostics Systems Inc. Raritan, NJ) and lysed using a commercially available ammonium chloride lysing reagent (Ortho Diagnostics Systems Inc). After washing in PBS-BSA, samples were analyzed on a FACScan flow cytometer (Becton Dickinson Immunocytometry Systems, San Jose, CA). Compensation was set using Calibrate Beads (Becton Dickinson Immunocytometry Systems) before each set of determinations. A minimum of 3,000 events were acquired in the lymphocyte gate in list mode. Data were analyzed using LYSYS I1 software (Becton Dickinson Immunocytometry Systems). For standard mitogenic stimulation, 250 pL whole blood was incubated in a 5% COz atmosphere with phytohemagglutinin (PHA) for 72 hours. Following red blood cell lysis, the sample was incubated with a 50-pg/mL propidium iodide solution containing RNAse at 1 mg/mL and 0.2% Nonidet P-40. Samples were analyzed using CellFIT software (Becton Dickinson Immunocytometry Systems) to determine the S-phase dimension. Results are expressed as the stimulation index (% stimulated S-phase cells/% unstimulated S-phase cells).
DNA extraction and Southern blot analysis. Nucleated cells from peripheral blood were used for DNA preparation. Genomic DNA isolation was performed with a salt-chloroform extraction method.I8 DNA samples were digested with EcoRI, BamHI, TaqI, and MspI (New England Biolabs, Beverly, MA) following the manufacturer's recommendations, electrophoresed in 0.7% agarose gels, transferred to nylon membrane (Hybond N; Amersham, Little Chalfont, UK), and hybridized under high-stringency conditions to a "Plabeled 1.2-kb CD43 cDNA probe." After a high-stringency wash, the membrane was exposed to x-ray film (X-omat AR; Eastman Kodak, Rochester, NY).
Polymerase chain reaction Abbreviation: NA, not available.
* A s reported in the pedigree (Fig 1) .
minute of extension at 72°C. followed by a final extension at 72°C for 4 minutes. The reactions were performed for 25 cycles on a Delphi thermal cycler (MJ Research. Watertown, MA). PCR products were analyzed on a 6% polyacrylamidel8.3-moln urea gel. After electrophoresis. the gel was dried and exposed to x-ray film.
RESULTS

Platelet Studies
Platelet coiints arid morphology. The characterization of the platelet population in affected family members is detailed in Table 1 . Unaffected family members showed normal platelet count and size, whereas in affected subjects platelet showed a heterogeneous platelet population with the presence of both small and giant platelets of diameters ranging from 1.8 to I2 pm (Fig 2) . The ultrastructural morphology of platelets was otherwise normal. No leukocyte inclusions, typical of May-Hegglin or Fechtner syndromes, were detected in thrombocytopenic subjects. The percentage of giant platelets was found to comprise 25% to 30% of the whole platelet population.
Platelet aggregation induced by ADP and collagen and ATP release induced by collagen were normal in all tested family members (1113, 111:4, 111:5, 111:6, and IV:2). In two subjects (1113 and IV:2), there was a decreased platelet aggregation induced by ristocetin. This finding may suggest a defective expression of platelet glycoprotein Ib, in agreement with other observations in WAS patients.'.'"
Ljlmpliocyte Studies
Results of immunologic phenotyping of the lymphocytes are shown in Table 1 . In agreement with the most common lymphocyte abnormalities described in WAS,' a decreased proportion of CD3, CD4, and CD19 cells, a low CD4/CD8 ratio, and an increased CD I6 cell population were variously detected in this family. In addition, a reduced response to PHA mitogen was detected in all tested family members (1V:2, 111:3, and 111:4). We also examined CD43 expression in most subjects by labeling CD3' peripheral blood lymphocytes with an antLCD43 MoAb. The fluorescence intensity was markedly reduced in family member III:3, and to a lesser extent in other tested family members (Table I) . CD43-CD3 double-labeling of peripheral blood lymphocytes is shown in Fig 3. This finding was confirmed by electron microscope analysis performed after staining of CD43 with an immunogold-labeled MoAb (Fig 4) .
Soiitliem Blot Analvsis
Southern blot analysis using four different restriction enzymes and a CD43 cDNA probe failed to detect gross abnormalities of the CD43 gene, ie, rearrangement or altered copy number, in affected family members. Unaffected relatives and control placenta DNA were used for comparison (data Platelet aggregation. 
Microsatellite Analysis
To rule out the possibility that CD43 point mutations undetectable by Southern blot analysis could be associated with the disease, we tried to determine whether a CD43 allele was shared by the affected family members. This analysis took advantage of the highly polymorphic microsatellite marker, SPN, which is located within the CD43 gene." SPN genotype analysis showed that the affected family members do not share a common CD43 allele (Fig 5) . These findings indicate that the CD43 gene is not linked to the disease observed in this family.
DISCUSSION
The family described in this report displays an autosomal dominant disorder phenotypically indistinguishable from classic X-linked WAS. Clinical and laboratory features reminiscent of WAS were present with different expressivity among affected family members. Thrombocytopenia, the only consistent laboratory finding, was variously associated with other clinical manifestations typical of WAS such as eczema, recurrent infections, nephropathy, nonseptic polyarthritis, severe allergic manifestations, autoimmune and inflammatory diseases. Furthermore, low IgM titers, high IgE values, low isoagglutinin titers, lymphocyte abnormalities, and defective CD43 were also detected in affected family members. The association of several manifestations in affected members and some peculiar characteristics of these manifestations (ie, short-term relapse of herpes zoster despite antiviral therapy, temporal association between infections, and eczema recrudescence2') strongly support the diagnosis of WAS-like syndrome. In addition, the variable expression of immune abnormalities in this kindred appears to be in agreement with the findings of a recent survey of WAS, which showed that typical manifestations of the disease vary from one patient to another and within the same kindred and are unpredictable during the clinical course of the disorder. 21 The most interesting feature of the family reported herein was the autosomal dominant transmission. The possible existence of autosomally transmitted WAS variants had only been hypothesized on the basis of reports of women presenting features typical of WAS without either structural alterations or nonrandom inactivation patterns of the X chromosome.22-26 However, these reports described sporadic cases that could not prove the existence of an autosomal segregation, which, in contrast, is evident in this family.
Because of the impaired expression of CD43 on lymphocytes as detected by both cytofluorimetry and immunoelectron microscopy, a mutation of the CD43 gene was first hypothesized as the possible cause of the autosomal disorder segregating in this family. However, Southern blot analysis failed to detect structural abnormalities of this gene, and use only. Another relevant feature of the disorder segregating in this family is the presence of asymptomatic thrombocytopenia, characterized by the presence of a broad spectrum of platelet size, including giant platelets. Typical WAS is characterized by small platelets, but in this family platelet size was highly heterogeneous and the presence of giant platelets was detected in all the affected members. In a number of inherited thrombocytopenic disorders such as Alport's, Bemard-Souher, Chediak-Higashi, Epstein, and Fechtner syndromes, von Willebrand variants, and grey-platelet syndrome, thrombocytopenia is associated with giant platelet^.'^." We were able to rule out the coexistence of these diseases, since we could not detect in any family member the functional, morphologic, or biochemical platelet defects and/or leukocyte inclusions typical of those disorders. However, the difference between the WASP gene and the one mutated in our family could account for the observed phenotypic differences.
The mechanism(s) underlying the abnormal platelet volume in WAS is still poorly understood. The observation that platelet size increases slightly after splenectomy led to the hypothesis that in WAS patients the platelet abnormality may be secondary to increased cell destruction?' However, more convincing findings argue in favor of a primary platelet defect related to altered thrombopoiesis?' In fact, several findings suggest that the molecular defect in WAS could influence the cytoskeletal architecture and/or organization, and may lead to ineffective thrombopoiesis with abnormal platelet size. In particular, it has been shown that CD43 can associate with actin filament^:^ which are known to be involved in megakaryocyte fragmentation. In addition, abnormal levels of platelet calpain, a Ca2'-dependent neutral protease interacting with cytoskeletal proteins, have been detected both in WAS patients3' and in patients with Montreal giant-platelet syndrome." Finally, sequence analysis of the WASP protein predicts that it might bind via its prolinerich motifs with SH3 domain-containing proteins. 13 Altogether, these findings indicate a possible association between WAS biochemical defect(s) and the mechanism of platelet production. This might also provide a framework for explaining the peculiar finding of giant platelets in our WAS family. It should also be remarked that an isolated thrombocytopenia with giant platelets had been previously described in a Saudi Arabian family. 33 The gene responsible for this disease mapped close to or at the same locus as classic WAS, thus raising the possibility that this disorder was a mild allelic variant of WAS. In addition, an atypical form of WAS has been recently describedz6 in a woman with random Xchromosome inactivation characterized by thrombocytopenia with platelets varying in size and MPV of 13.9 fL.
In conclusion, we have described the first family affected by an autosomally transmitted variant of WAS, which may contribute considerably to the understanding of the molecular basis of classic X-linked WAS. and this new disorder.
